HSA has granted Flowflex ART an extension of validity to 30th June 2023

HSA has granted Flowflex ART an extension of validity to 30th June 2023

HSA has announced that COVID-19 diagnostic tests authorised under Pandemic Special Access Route (PSAR) submission should be prepared for a transition into full registration. Companies that do not submit their ART kits for full registration will not be authorised for sales after December 31, 2022. 

To avoid disrupting local COVID testing services, HSA has extended the PSAR authorisation for ART kits that have been submitted for full registration in 2022. 

With that, we are pleased to share that the Flowflex ART has been granted a PSAR extension till 30th June 2023. Flowflex users can be assured that we meet the appropriate MOH standards for safety, quality, and efficacy.